Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC)

By Vestermark Lene   Jacobsen Anders   Qvortrup Camilla   Hansen Flemming   Bisgaard Claus   Baatrup Gunnar   Rasmussen Peter   Pfeiffer Per  

Acta Oncologica, Vol. 47, Iss. 3, 2007-12 ,pp. : 428-433

Informa Healthcare

Access to resources Recommend Favorite

High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): A phase I trial

By Vestermark Lene W.   Jensen Helle A.   Pfeiffer Per  

Acta Oncologica, Vol. 51, Iss. 3, 2012-03 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite

Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer

By las Heras Manuel  

Clinical and Translational Oncology, Vol. 15, Iss. 4, 2013-04 ,pp. : 294-299

Springer Publishing Company

Access to resources Recommend Favorite

A phase I trial of S-1 with concurrent radiotherapy in patients with locally recurrent rectal cancer

By Wada Hitoshi  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 273-278

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer

By            

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 951-959

Spandidos Publications

Access to resources Recommend Favorite